A comparison between the Plateletworks™-assay and light transmittance aggregometry for monitoring the inhibitory effects of clopidogrel

International Journal of Cardiology

Volumn 140, Issue 1, 2010, Pages 123-126

  van Werkum, Jochem W ^a   Kleibeuker, Marjolein ^a   Postma, Sonja ^a   Bouman, Heleen J ^a   Elsenberg, Ellen H A M ^a   ten Berg, Jurriën M ^a   Hackeng, Christian M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Clopidogrel; Platelets; Plateletworks

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIGHT TRANSMITTANCE AGGREGOMETRY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; BLOOD CLOTTING PARAMETERS; COMPARATIVE STUDY; DRUG EFFECT; DRUG MONITORING; HOSPITAL INFORMATION SYSTEM; LETTER; METHODOLOGY; STANDARD; THROMBOCYTE;

BLOOD PLATELETS; DRUG MONITORING; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; TICLOPIDINE;

EID: 77949489504     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.10.046     Document Type: Article

References (5)

1. Steinhubl S.R., Berger P.B., Mann III J.T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (2002) 2411-2420
2. Geisler T., Langer H., Wydymus M., et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J 27 (2006) 2420-2425
3. van Werkum J.W., Hackeng C.M., Smit A.C., van't Hof A.W., Verheugt F., and Ten Berg J.M. Monitoring antiplatelet therapy with point-of-care platelet function assays: a review of the evidence. Future Cardiol 8 (2008) 33-55
4. Lakkis N.M., George S., Thomas E., Ali M., Guyer K., and Carville D. Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors. Catheter Cardiovasc Interv 53 (2001) 346-351
5. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150